Browse Category

Investing Tips News 20 December 2025 - 24 December 2025

Citigroup Stock (C) After the Bell on Dec. 23, 2025: New 52-Week High, After-Hours Check, and What to Watch Before Markets Open Tomorrow

Citigroup Stock (C) After the Bell on Dec. 23, 2025: New 52-Week High, After-Hours Check, and What to Watch Before Markets Open Tomorrow

Citigroup Inc. (NYSE: C) ended Tuesday, December 23, 2025, with a fresh burst of momentum: the stock rose 1.11% to close at $119.40, marking its fifth straight daily gain and setting a new 52-week high in regular trading. In extended trading, the move held up, with shares around $119.65 at about 5:41 p.m. ET, modestly higher than the closing print.…
Palantir (PLTR) Stock After Hours Today, Dec. 23, 2025: What Happened After the Bell—and What to Watch Before the Dec. 24 Market Open

Palantir (PLTR) Stock After Hours Today, Dec. 23, 2025: What Happened After the Bell—and What to Watch Before the Dec. 24 Market Open

Palantir Technologies Inc. (NASDAQ: PLTR) ended Tuesday’s regular session essentially flat, then slipped modestly in after-hours trading—keeping the spotlight on a stock that has become one of 2025’s most talked-about AI names heading into a holiday-shortened Christmas Eve session. Here’s the full after-the-bell snapshot for 23.12.2025 (December 23, 2025), plus the most important news, forecasts, and analyses published today—and what…
Visa Stock After Hours (Dec. 22, 2025): V Closes at $352, Holds Flat Late as Fiserv “Agentic Commerce” Deal and ATM Fee Settlement Hit the Tape — What to Know Before Tuesday’s Open

Visa Stock After Hours (Dec. 22, 2025): V Closes at $352, Holds Flat Late as Fiserv “Agentic Commerce” Deal and ATM Fee Settlement Hit the Tape — What to Know Before Tuesday’s Open

Visa Inc. (NYSE: V) shares ended Monday, December 22, 2025, higher and then traded essentially flat after the closing bell, as investors balanced a broader holiday-week equity rebound with two Visa-linked storylines: a new “agentic commerce” partnership announced by Fiserv and a fresh round of headlines around a long-running ATM fee antitrust case involving Visa and Mastercard. StockAnalysis Visa stock…
Palo Alto Networks (PANW) Stock After Hours: What Happened on Dec. 22, 2025—and What to Watch Before the Market Opens Tuesday

Palo Alto Networks (PANW) Stock After Hours: What Happened on Dec. 22, 2025—and What to Watch Before the Market Opens Tuesday

Palo Alto Networks, Inc. (NASDAQ: PANW) ended Monday’s session (Dec. 22, 2025) firmly in the green—and then barely budged after the closing bell, a sign that investors didn’t see a fresh, market-moving headline hit the tape late in the day. Shares closed at $189.49, up 1.40%, and traded slightly higher in after-hours around $189.60 as of 7:52 p.m. ET. StockAnalysis…
Applied Materials (AMAT) Stock After Hours Today (Dec. 22, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Applied Materials (AMAT) Stock After Hours Today (Dec. 22, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

Applied Materials, Inc. (NASDAQ: AMAT) finished Monday’s session on a strong note—and then stayed relatively steady after the closing bell—heading into a holiday-shortened week where lighter liquidity and a busy U.S. data calendar could amplify moves in semiconductor stocks. AMAT stock price after the bell: where Applied Materials stands tonight Applied Materials shares closed Monday, December 22, 2025 at $259.01,…
Tesla Stock (TSLA) After Hours Today (Dec. 22, 2025): Record-High Momentum, Robotaxi Headlines, and What to Watch Before Tuesday’s Open

Tesla Stock (TSLA) After Hours Today (Dec. 22, 2025): Record-High Momentum, Robotaxi Headlines, and What to Watch Before Tuesday’s Open

Tesla, Inc. (NASDAQ: TSLA) finished Monday’s session with fresh “near-$500” momentum — and the story powering the tape into the close was familiar: autonomy optimism, a high-profile legal win for CEO Elon Musk, and holiday-week positioning as liquidity thins out. Tesla shares closed at $488.73, up about 1.6%, after trading as high as $498.7 intraday. In early after-hours trading, the…
Home Depot Stock (HD): What Investors Should Know Before the Market Opens on Dec. 22, 2025

Home Depot Stock (HD): What Investors Should Know Before the Market Opens on Dec. 22, 2025

Home Depot (NYSE: HD) heads into Monday’s U.S. stock market open with investors balancing three big forces: a cautious near-term outlook for fiscal 2026, signs of a housing market that’s stabilizing but still constrained, and a company strategy that’s leaning harder into Pro customers, distribution, and productivity initiatives. Home Depot Investor Relations Friday’s close added a fresh reminder that sentiment…
American Express Stock (AXP) After Hours on Dec. 19, 2025: What Investors Need to Know Before the Next Market Open

American Express Stock (AXP) After Hours on Dec. 19, 2025: What Investors Need to Know Before the Next Market Open

American Express Company (NYSE: AXP) finished Friday’s session little changed from where it spent much of the day—near recent highs—before edging slightly higher in after-hours trading. With the U.S. market closed on Saturday, Dec. 20, the next regular session begins Monday, Dec. 22 (9:30 a.m. ET). Here’s what matters for AXP heading into the next open, including the key company…
Newmont (NEM) Stock After the Bell on Dec. 19, 2025: After-Hours Moves, Today’s Key News, and What to Watch Before the Next Market Open

Newmont (NEM) Stock After the Bell on Dec. 19, 2025: After-Hours Moves, Today’s Key News, and What to Watch Before the Next Market Open

Newmont Corporation (NYSE: NEM) ended Friday, December 19, 2025, on a strong note, finishing the regular session up nearly 2% and trading just shy of the stock’s recent highs. In after-hours trading, shares were little changed to slightly higher, suggesting no new, market-moving corporate headline hit immediately after the closing bell—but the bigger story for investors is what’s happening around…
Robinhood (HOOD) Stock After Hours Today (Dec. 19, 2025): Late Trading Move, Fresh Headlines, Analyst Forecasts, and What to Watch Before the Next Open

Robinhood (HOOD) Stock After Hours Today (Dec. 19, 2025): Late Trading Move, Fresh Headlines, Analyst Forecasts, and What to Watch Before the Next Open

Robinhood Markets, Inc. (NASDAQ: HOOD) ended Friday’s regular session higher and then nudged up again in late after-hours trading, as investors digested a busy week of headlines around prediction markets and a fresh update tied to the company’s Canada expansion plans. By the closing bell, HOOD finished around $121.3 (up roughly 3.6% on the day), and in late after-hours it…
Salesforce (CRM) Stock After Hours Today (Dec. 19, 2025): What’s Moving Shares and What to Watch Before Monday’s Market Open

Salesforce (CRM) Stock After Hours Today (Dec. 19, 2025): What’s Moving Shares and What to Watch Before Monday’s Market Open

Salesforce, Inc. (NYSE: CRM) finished Friday’s session higher and held firm in extended trading as investors weighed a burst of “agentic AI” headlines, fresh Wall Street calls, and broader tech momentum into year-end. CRM shares closed regular trading on Friday, Dec. 19, 2025 at $259.91, up 0.80%, after swinging through a wide intraday range as volatility picked up during December’s…
CoreWeave Stock (CRWV) After Hours on Dec. 19, 2025: What Investors Need to Know Before the Next Market Open

CoreWeave Stock (CRWV) After Hours on Dec. 19, 2025: What Investors Need to Know Before the Next Market Open

CoreWeave, Inc. (NASDAQ: CRWV) is ending the week with a sharp rebound that has traders recalibrating expectations going into the next session. After a powerful Friday rally, the stock is holding near the day’s highs in after-hours trading, as investors digest two headline catalysts: a bullish-but-cautious Citi call and CoreWeave’s role in the U.S. Department of Energy’s Genesis Mission. TradingView…
1 4 5 6 7 8 11

Stock Market Today

  • Pfizer Q4 Preview: Non-Oncology Segment Sales Outlook and Market Impact
    January 19, 2026, 11:10 AM EST. Pfizer (PFE) is scheduled to report Q4 and full-year 2025 earnings on Feb. 3. While oncology sales account for over 28% of revenues, investor focus also shifts to non-oncology segments including Primary Care and Specialty Care. Key non-oncology products include Eliquis anticoagulant, Prevnar vaccines, COVID-19 vaccine Comirnaty, and newer drugs like RSV vaccine Abrysvo and migraine treatment Nurtec. Eliquis alliance revenues are expected to rise to $2.1 billion despite generic pressures. Prevnar vaccine sales likely declined in the U.S. but increased internationally, estimated at $1.64 billion. COVID-19 medication sales fell due to narrower vaccine recommendations and lower infections. In Specialty Care, Vyndaqel sales remain strong at an estimated $1.66 billion, while Xeljanz and Enbrel may have weakened. Pfizer's stock dropped 2.5% in past year, underperforming the industry, but trades at a forward price/earnings ratio of 8.58, suggesting valuation appeal.
Go toTop